nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—UGT2B17—Phase II conjugation—COMT—conduct disorder	0.0604	0.0604	CbGpPWpGaD
Losartan—ACE—Peptide hormone metabolism—CGA—conduct disorder	0.0548	0.0548	CbGpPWpGaD
Losartan—UGT1A3—Estrogen metabolism—COMT—conduct disorder	0.0529	0.0529	CbGpPWpGaD
Losartan—UGT2B7—Estrogen metabolism—COMT—conduct disorder	0.045	0.045	CbGpPWpGaD
Losartan—SLC2A9—NRF2 pathway—SLC6A4—conduct disorder	0.0403	0.0403	CbGpPWpGaD
Losartan—UGT1A1—Estrogen metabolism—COMT—conduct disorder	0.0366	0.0366	CbGpPWpGaD
Losartan—UGT2B17—Biological oxidations—COMT—conduct disorder	0.0354	0.0354	CbGpPWpGaD
Losartan—UGT2B17—Biological oxidations—MAOA—conduct disorder	0.0351	0.0351	CbGpPWpGaD
Losartan—UGT2B17—Metapathway biotransformation—COMT—conduct disorder	0.0349	0.0349	CbGpPWpGaD
Losartan—UGT1A10—Metapathway biotransformation—COMT—conduct disorder	0.0215	0.0215	CbGpPWpGaD
Losartan—CYP1A2—Methylation—COMT—conduct disorder	0.0214	0.0214	CbGpPWpGaD
Losartan—SLC2A9—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0203	0.0203	CbGpPWpGaD
Losartan—SLC22A12—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0186	0.0186	CbGpPWpGaD
Losartan—UGT1A3—Phase II conjugation—COMT—conduct disorder	0.0149	0.0149	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—CGA—conduct disorder	0.0134	0.0134	CbGpPWpGaD
Losartan—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.0134	0.0134	CbGpPWpGaD
Losartan—UGT1A3—NRF2 pathway—SLC6A4—conduct disorder	0.0131	0.0131	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0129	0.0129	CbGpPWpGaD
Losartan—UGT2B7—Phase II conjugation—COMT—conduct disorder	0.0126	0.0126	CbGpPWpGaD
Losartan—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.0116	0.0116	CbGpPWpGaD
Losartan—UGT2B7—NRF2 pathway—SLC6A4—conduct disorder	0.0111	0.0111	CbGpPWpGaD
Losartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.0107	0.0107	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—CGA—conduct disorder	0.0103	0.0103	CbGpPWpGaD
Losartan—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.0103	0.0103	CbGpPWpGaD
Losartan—UGT1A1—Phase II conjugation—COMT—conduct disorder	0.0103	0.0103	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—CGA—conduct disorder	0.00981	0.00981	CbGpPWpGaD
Losartan—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.00908	0.00908	CbGpPWpGaD
Losartan—UGT1A1—NRF2 pathway—SLC6A4—conduct disorder	0.00904	0.00904	CbGpPWpGaD
Losartan—UGT1A3—Biological oxidations—COMT—conduct disorder	0.0087	0.0087	CbGpPWpGaD
Losartan—UGT1A3—Biological oxidations—MAOA—conduct disorder	0.00864	0.00864	CbGpPWpGaD
Losartan—UGT1A3—Metapathway biotransformation—COMT—conduct disorder	0.00858	0.00858	CbGpPWpGaD
Losartan—AGTR1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00842	0.00842	CbGpPWpGaD
Losartan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.0074	0.0074	CbGpPWpGaD
Losartan—UGT2B7—Biological oxidations—COMT—conduct disorder	0.00739	0.00739	CbGpPWpGaD
Losartan—UGT2B7—Biological oxidations—MAOA—conduct disorder	0.00734	0.00734	CbGpPWpGaD
Losartan—UGT2B7—Metapathway biotransformation—COMT—conduct disorder	0.00729	0.00729	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00722	0.00722	CbGpPWpGaD
Losartan—AGTR1—G alpha (q) signalling events—HTR2A—conduct disorder	0.00711	0.00711	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00697	0.00697	CbGpPWpGaD
Losartan—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00683	0.00683	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00636	0.00636	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00622	0.00622	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—COMT—conduct disorder	0.00605	0.00605	CbGpPWpGaD
Losartan—UGT1A1—Biological oxidations—COMT—conduct disorder	0.00601	0.00601	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—MAOA—conduct disorder	0.006	0.006	CbGpPWpGaD
Losartan—UGT1A1—Biological oxidations—MAOA—conduct disorder	0.00597	0.00597	CbGpPWpGaD
Losartan—UGT1A1—Metapathway biotransformation—COMT—conduct disorder	0.00593	0.00593	CbGpPWpGaD
Losartan—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00591	0.00591	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CGA—conduct disorder	0.00555	0.00555	CbGpPWpGaD
Losartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.0055	0.0055	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—DRD4—conduct disorder	0.0055	0.0055	CbGpPWpGaD
Losartan—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00528	0.00528	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CGA—conduct disorder	0.00504	0.00504	CbGpPWpGaD
Losartan—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00481	0.00481	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00471	0.00471	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00468	0.00468	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00459	0.00459	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00418	0.00418	CbGpPWpGaD
Losartan—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00411	0.00411	CbGpPWpGaD
Losartan—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.00376	0.00376	CbGpPWpGaD
Losartan—CYP3A5—Biological oxidations—COMT—conduct disorder	0.00365	0.00365	CbGpPWpGaD
Losartan—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.00363	0.00363	CbGpPWpGaD
Losartan—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.0036	0.0036	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—HTR2A—conduct disorder	0.00359	0.00359	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—CGA—conduct disorder	0.00329	0.00329	CbGpPWpGaD
Losartan—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00317	0.00317	CbGpPWpGaD
Losartan—CYP2C8—Biological oxidations—COMT—conduct disorder	0.00316	0.00316	CbGpPWpGaD
Losartan—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00314	0.00314	CbGpPWpGaD
Losartan—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.00312	0.00312	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—DRD4—conduct disorder	0.00311	0.00311	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—CGA—conduct disorder	0.0031	0.0031	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CGA—conduct disorder	0.00298	0.00298	CbGpPWpGaD
Losartan—CYP2C19—Biological oxidations—COMT—conduct disorder	0.00282	0.00282	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—DRD4—conduct disorder	0.00282	0.00282	CbGpPWpGaD
Losartan—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.0028	0.0028	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—CGA—conduct disorder	0.0028	0.0028	CbGpPWpGaD
Losartan—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.00279	0.00279	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00271	0.00271	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00271	0.00271	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00269	0.00269	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00268	0.00268	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—EP300—conduct disorder	0.00259	0.00259	CbGpPWpGaD
Losartan—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00258	0.00258	CbGpPWpGaD
Losartan—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00256	0.00256	CbGpPWpGaD
Losartan—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00254	0.00254	CbGpPWpGaD
Losartan—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.00254	0.00254	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0024	0.0024	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00239	0.00239	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—WASF1—conduct disorder	0.00238	0.00238	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—CGA—conduct disorder	0.00228	0.00228	CbGpPWpGaD
Losartan—CYP1A2—Biological oxidations—COMT—conduct disorder	0.0022	0.0022	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00219	0.00219	CbGpPWpGaD
Losartan—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.00219	0.00219	CbGpPWpGaD
Losartan—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.00217	0.00217	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00209	0.00209	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CGA—conduct disorder	0.00209	0.00209	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—HTR2A—conduct disorder	0.00203	0.00203	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00187	0.00187	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—HTR2A—conduct disorder	0.00184	0.00184	CbGpPWpGaD
Losartan—CYP3A4—Biological oxidations—COMT—conduct disorder	0.0017	0.0017	CbGpPWpGaD
Losartan—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00169	0.00169	CbGpPWpGaD
Losartan—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00167	0.00167	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—DRD4—conduct disorder	0.00167	0.00167	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—COMT—conduct disorder	0.00149	0.00149	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—MAOA—conduct disorder	0.00148	0.00148	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—COMT—conduct disorder	0.0014	0.0014	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—MAOA—conduct disorder	0.00139	0.00139	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CGA—conduct disorder	0.00138	0.00138	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00135	0.00135	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—COMT—conduct disorder	0.00126	0.00126	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—MAOA—conduct disorder	0.00126	0.00126	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CGA—conduct disorder	0.0012	0.0012	CbGpPWpGaD
Losartan—ALB—Metabolism—CGA—conduct disorder	0.00119	0.00119	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—HTR2A—conduct disorder	0.00109	0.00109	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00109	0.00109	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CGA—conduct disorder	0.00107	0.00107	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CGA—conduct disorder	0.00104	0.00104	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—COMT—conduct disorder	0.00103	0.00103	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—MAOA—conduct disorder	0.00102	0.00102	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CGA—conduct disorder	0.000976	0.000976	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—COMT—conduct disorder	0.000942	0.000942	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—MAOA—conduct disorder	0.000935	0.000935	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000907	0.000907	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CGA—conduct disorder	0.000834	0.000834	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CGA—conduct disorder	0.000643	0.000643	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—EP300—conduct disorder	0.000638	0.000638	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—COMT—conduct disorder	0.000625	0.000625	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—MAOA—conduct disorder	0.00062	0.00062	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—EP300—conduct disorder	0.000601	0.000601	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—EP300—conduct disorder	0.000576	0.000576	CbGpPWpGaD
Losartan—ALB—Hemostasis—EP300—conduct disorder	0.000569	0.000569	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—EP300—conduct disorder	0.000542	0.000542	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—COMT—conduct disorder	0.000541	0.000541	CbGpPWpGaD
Losartan—ALB—Metabolism—COMT—conduct disorder	0.000538	0.000538	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—MAOA—conduct disorder	0.000537	0.000537	CbGpPWpGaD
Losartan—ALB—Metabolism—MAOA—conduct disorder	0.000534	0.000534	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000521	0.000521	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000518	0.000518	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—COMT—conduct disorder	0.000483	0.000483	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—MAOA—conduct disorder	0.00048	0.00048	CbGpPWpGaD
Losartan—ABCB1—Metabolism—COMT—conduct disorder	0.000471	0.000471	CbGpPWpGaD
Losartan—ABCB1—Metabolism—MAOA—conduct disorder	0.000468	0.000468	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000465	0.000465	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—EP300—conduct disorder	0.000441	0.000441	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—COMT—conduct disorder	0.00044	0.00044	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—MAOA—conduct disorder	0.000437	0.000437	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000424	0.000424	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—EP300—conduct disorder	0.000404	0.000404	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—COMT—conduct disorder	0.000376	0.000376	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—MAOA—conduct disorder	0.000374	0.000374	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000362	0.000362	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—COMT—conduct disorder	0.00029	0.00029	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—MAOA—conduct disorder	0.000288	0.000288	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—EP300—conduct disorder	0.000268	0.000268	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—EP300—conduct disorder	0.000232	0.000232	CbGpPWpGaD
Losartan—ALB—Metabolism—EP300—conduct disorder	0.000231	0.000231	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—EP300—conduct disorder	0.000207	0.000207	CbGpPWpGaD
Losartan—ABCB1—Metabolism—EP300—conduct disorder	0.000202	0.000202	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—EP300—conduct disorder	0.000189	0.000189	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—EP300—conduct disorder	0.000161	0.000161	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—EP300—conduct disorder	0.000125	0.000125	CbGpPWpGaD
